ArticleMolecular cancer research : MCR2023

Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells.

Katherine Sullivan-Reed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.